Effects of flecainide on the rate dependence of atrial refractoriness, atrial repolarization and atrioventricular node conduction in anesthetized dogs.

[1]  M. Allessie,et al.  Mode of Action of a New Class IC Drug (ORG 7797) Against Atrial Fibrillation in Conscious Doges , 1991, Journal of cardiovascular pharmacology.

[2]  K. Lie,et al.  The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. , 1990, Journal of the American College of Cardiology.

[3]  T. Colatsky,et al.  Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. , 1990, Circulation.

[4]  S Nattel,et al.  Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues. , 1990, Circulation.

[5]  T. Colatsky,et al.  Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes. , 1990, Circulation.

[6]  S. Nattel,et al.  Electrophysiological Effects of α‐Adrenergic Stimulation , 1990, Pacing and clinical electrophysiology : PACE.

[7]  J. Le Heuzey,et al.  Cellular electrophysiological effects of flecainide on human atrial fibres. , 1990, Cardiovascular research.

[8]  D. Snyders,et al.  Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. , 1990, Circulation.

[9]  J. Davy,et al.  Comparison of the Cardiac Electrophysiological Effects of Flecainide and Hydroquinidine in Anesthetized Dog: Concentration‐Response Relationship , 1990, Journal of cardiovascular pharmacology.

[10]  S. Nattel,et al.  Amplification of flecainide-induced ventricular conduction slowing by exercise. A potentially significant clinical consequence of use-dependent sodium channel blockade. , 1989, Circulation.

[11]  J. Kingma,et al.  Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. , 1989, The American journal of cardiology.

[12]  G. Vassort,et al.  Inhibition of ICa in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin. , 1989, The American journal of physiology.

[13]  E. Antman,et al.  Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter. , 1988, Journal of the American College of Cardiology.

[14]  P. Coumel,et al.  Oral flecainide for prophylaxis of paroxysmal atrial fibrillation. , 1988, The American journal of cardiology.

[15]  J. Goy,et al.  Restoration of sinus rhythm with flecainide in patients with atrial fibrillation. , 1988, The American journal of cardiology.

[16]  I. V. Van Gelder,et al.  Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. , 1988, European heart journal.

[17]  G. Feld,et al.  Effects of N-acetylprocainamide and recainam in the pharmacologic conversion and suppression of experimental canine atrial flutter: significance of changes in refractoriness and conduction. , 1988, Journal of cardiovascular pharmacology.

[18]  M R Franz,et al.  Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ. , 1988, Circulation.

[19]  G. Klein,et al.  Propafenone for prevention of recurrent atrial fibrillation. , 1988, The American journal of cardiology.

[20]  B. Gersh,et al.  Propafenone for paroxysmal atrial fibrillation. , 1988, The American journal of cardiology.

[21]  M. Jenkins,et al.  Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation. , 1987, The American journal of cardiology.

[22]  J. Goy,et al.  Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. , 1986, The American journal of cardiology.

[23]  R. Lal,et al.  Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate. , 1986, The American journal of cardiology.

[24]  G. Feld,et al.  Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction. , 1986, Circulation.

[25]  M. Shenasa,et al.  Evaluation of flecainide acetate in rapid atrial fibrillation complicating wolff‐parkinson‐white syndrome , 1985, Clinical cardiology.

[26]  J. R. Schmid,et al.  Electrophysiologic effects of flecainide acetate and its major metabolites in the canine heart. , 1985, The American journal of cardiology.

[27]  L. D. Davis,et al.  Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. , 1985, Journal of the American College of Cardiology.

[28]  E. Williams.  A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs , 1984 .

[29]  J. Ruskin,et al.  Electrophysiologic properties of flecainide acetate. , 1984, The American journal of cardiology.

[30]  A. Camm,et al.  Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias. , 1983, The American journal of cardiology.

[31]  B. Pitt,et al.  Oral flecainide acetate for the treatment of ventricular arrhythmias. , 1981, The New England journal of medicine.

[32]  J. Spear,et al.  Electrophysiological Effects of a New Antiarrhythmic Agent, Flecainide, on the Intact Canine Heart , 1979, Journal of cardiovascular pharmacology.

[33]  E Ruiz-Ceretti,et al.  Action Potential Changes under Varied [Na+]0 and [Ca2+]0 Indicating the Existence of Two Inward Currents in Cells of the Rabbit Atrioventricular Node , 1976, Circulation research.

[34]  W. Rheinboldt,et al.  A COMPUTER MODEL OF ATRIAL FIBRILLATION. , 1964, American heart journal.

[35]  E. Pritchett,et al.  Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. , 1991, Circulation.

[36]  S. Nattel,et al.  Antiarrhythmic actions of diltiazem during experimental atrioventricular reentrant tachycardias. Importance of use-dependent calcium channel-blocking properties. , 1990, Circulation.

[37]  J. Billette,et al.  Atrioventricular nodal activation during periodic premature stimulation of the atrium. , 1987, The American journal of physiology.

[38]  M. Allessie,et al.  Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation , 1985 .

[39]  R. Lewis,et al.  Chronic epicardial His bundle recordings in awake nonsedated dogs: a new method. , 1983, American heart journal.